
Swiss banking giant UBS is reportedly preparing for another significant round of job cuts, with plans to eliminate approximately 10,000 additional positions by 2027. This strategic move is driven by the protracted and costly integration of Credit Suisse, which continues to pressure profitability. Concurrently, potential regulatory relief may create future opportunities for shareholder returns.
A Deepening Restructuring Effort
The latest reduction plan extends a sweeping restructuring initiative that began following UBS's acquisition of Credit Suisse in the summer of 2023. Since the takeover, the bank has already cut about 15,000 jobs, reducing its full-time employee count from 119,100 to 104,427 by the end of September. The proposed elimination of a further 10,000 roles would shrink the total workforce to roughly 95,000.
The bank's home market will not be spared, with an estimated 3,000 positions slated for removal in Switzerland. These measures represent a tightening of pressure to deliver the promised synergies from the historic merger.
Key Data Points:
* New Reduction Target: 10,000 additional positions by 2027
* Cuts Since Acquisition: 15,000 jobs already removed
* Cost-Income Ratio: Stands at 77%, notably higher than U.S. peers like Morgan Stanley at 67%
* Savings Goal: $13 billion total, with $10 billion already achieved
Integration Challenges Weigh on Performance
The slower-than-expected integration process is a primary driver of elevated expenses. While 85% of client accounts have been migrated, the complex technology merger remains ongoing, consuming hundreds of millions in funds. CEO Sergio Ermotti initially announced a $13 billion savings target. By September 2025, 77% of this goal had been met—a pace apparently insufficient to restore international competitiveness.
UBS's cost efficiency continues to lag significantly behind its major American rivals. A cost-income ratio of 77% is considered elevated for a global leader in wealth management.
Regulatory Relief Offers a Counterbalance
Despite the challenging cost outlook, UBS shares advanced by 4.65% this past Friday. This gain was fueled by reports suggesting Swiss authorities may ease capital requirements, potentially freeing up to $11 billion. Such regulatory relief could provide the bank with increased flexibility for shareholder-friendly actions like higher dividends or share buybacks.
The news of further job cuts therefore arrives amid a market sentiment torn between hopes for regulatory easing and the acknowledged necessity for stringent cost-cutting measures.
Analysts Maintain a Cautiously Optimistic View
RBC Capital Markets reiterated its "buy" rating over the weekend, affirming a price target of 38.00 Swiss francs. Analyst Anke Reingen pointed to the long-term potential within the wealth management division. She emphasized, however, that the bank must demonstrate an ability to lower its cost base with sufficient speed. The planned workforce reduction is viewed as a clear signal that management is prepared to take decisive action to secure profitability. UBS stock closed Friday's session at 34.90 euros, trading near its 52-week high of 36.00 euros.
Ad
UBS Stock: New Analysis - 07 December
Fresh UBS information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Read our updated UBS analysis...
| Kurs | Vortag | Veränderung | Datum/Zeit | |
| 41,57 $ | 41,06 $ | 0,51 $ | +1,24% | 24.04./18:56 |
| ISIN | WKN | Jahreshoch | Jahrestief | |
| CH0244767585 | A12DFH | 49,36 $ | 29,33 $ | |
| Handelsplatz | Letzter | Veränderung | Zeit |
|
|
35,39 € | +0,63% | 16:44 |
| Nasdaq | 41,57 $ | +1,24% | 18:55 |
| NYSE | 41,535 $ | +1,21% | 18:50 |
| Frankfurt | 35,34 € | +0,83% | 16:44 |
| AMEX | 41,38 $ | +0,78% | 17:38 |
| Stuttgart | 35,38 € | +0,68% | 18:33 |
| Düsseldorf | 35,18 € | +0,03% | 12:30 |
| Xetra | 35,42 € | -0,17% | 17:35 |
| Hannover | 35,39 € | -0,23% | 17:25 |
| Hamburg | 35,39 € | -0,28% | 17:25 |
| München | 35,35 € | -2,16% | 08:14 |
|
| Antw. | Thema | Zeit |
| 498 | UBS mit Erholungs Potential | 04.02.26 |








